Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2077 to 2126 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 2077\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent iroquois-class homeodomain protein irx-4 (iroquois homeobox protein 4). [source:swissprot;acc:p78413]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 221.703\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 223.483\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00803\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2078\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent fidgetin-like 1. [source:refseq;acc:nm\_022116]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 215.511\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.814\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00794\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2079\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphatidylinositol-4-phosphate 3-kinase c2 domain-containing gamma polypeptide (ec 2.7.1.154) (phosphoinositide 3-kinase-c2-gamma) (ptdins-3-kinase c2 gamma) (pi3k-c2gamma). [source:swissprot;acc:o75747]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 215.967\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 214.28\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00787\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2080\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphatidylinositol-4-phosphate 3-kinase c2 domain-containing beta polypeptide (ec 2.7.1.154) (phosphoinositide 3-kinase-c2-beta) (ptdins-3-kinase c2 beta) (pi3k-c2beta) (c2-pi3k). [source:swissprot;acc:o00750]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2081\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dynamin 1-like protein isoform 3; dynamin-like protein. [source:refseq;acc:nm\_005690]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2082\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphoinositide-3-kinase, class 2, alpha polypeptide; c2-containing phosphatidylinositol kinase. [source:refseq;acc:nm\_002645]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2083\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar protein sorting 16 (hvps16). [source:swissprot;acc:q9h269]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 215.258\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.579\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00786\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2084\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (ec 2.6.1.16) (hexosephosphate aminotransferase 1) (d-fructose-6- phosphate amidotransferase 1) (gfat 1) (gfat1). [source:swissprot;acc:q06210]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 222.548\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 224.293\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00784\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2085\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent isocitrate dehydrogenase [nad] subunit alpha, mitochondrial precursor (ec 1.1.1.41) (isocitric dehydrogenase) (nad+-specific icdh). [source:swissprot;acc:p50213]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 222.58\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 224.32\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00782\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2086\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent isocitrate dehydrogenase [nad] subunit beta, mitochondrial precursor (ec 1.1.1.41) (isocitric dehydrogenase) (nad+-specific icdh). [source:swissprot;acc:o43837]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2087\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent isocitrate dehydrogenase [nad] subunit gamma, mitochondrial precursor (ec 1.1.1.41) (isocitric dehydrogenase) (nad+-specific icdh). [source:swissprot;acc:p51553]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2088\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent maguk p55 subfamily member 3 (mpp3 protein) (discs, large homolog 3). [source:swissprot;acc:q13368]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.124\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.433\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00781\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2089\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serologically defined colon cancer antigen 16. [source:refseq;acc:nm\_006649]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 215.144\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.479\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0078\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2090\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (ec 2.6.1.16) (hexosephosphate aminotransferase 2) (d-fructose-6- phosphate amidotransferase 2) (gfat 2) (gfat2). [source:swissprot;acc:o94808]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 222.609\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 224.344\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00779\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2091\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rna, u transporter 1; snurportin-1. [source:refseq;acc:nm\_005701]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 211.679\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 210.052\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00775\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2092\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent evolutionarily conserved signaling intermediate in toll pathway; ecsit. [source:refseq;acc:nm\_016581]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 211.992\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 210.369\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00772\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2093\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribokinase (ec 2.7.1.15). [source:swissprot;acc:q9h477]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 209.994\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 208.387\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00771\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2094\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pms1 protein homolog 2 (dna mismatch repair protein pms2). [source:swissprot;acc:p54278]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.321\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 205.747\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00765\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2095\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent polymerase (dna directed) sigma; topoisomerase-related function protein 4-1; polymerase (dna-directed) sigma. [source:refseq;acc:nm\_006999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 229.266\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 227.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00763\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2096\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent limkain beta 2. [source:refseq;acc:nm\_025140]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.723\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.089\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00756\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2097\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent delta-interacting protein a (hepatitis delta antigen interacting protein a). [source:swissprot;acc:q15834]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 214.979\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00745\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2098\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ret finger protein 2 (leukemia associated protein 5) (b-cell chronic lymphocytic leukemia tumor suppressor leu5) (putative tumor suppressor rfp2) (tripartite motif protein 13). [source:swissprot;acc:o60858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 177.515\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 178.831\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00741\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2099\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-like protein smt3a. [source:swissprot;acc:p55854]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 211.71\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 213.27\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00737\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-like protein smt3b (sentrin 2) (hsmt3). [source:swissprot;acc:p55855]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent acrc protein; putative nuclear protein. [source:refseq;acc:nm\_052957]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2102\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 5a (eif-5a) (eif-4d) (rev- binding factor). [source:swissprot;acc:p10159]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 208.727\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 210.263\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00736\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transketolase (ec 2.2.1.1) (tk). [source:swissprot;acc:p29401]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 214.666\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.236\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00731\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent thymidylate kinase (ec 2.7.4.9) (dtmp kinase). [source:swissprot;acc:p23919]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 209.328\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.813\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00729\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eif-5a2 protein. [source:refseq;acc:nm\_020390]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 208.591\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 210.111\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent insulin gene enhancer protein isl-1 (islet-1). [source:swissprot;acc:p20663]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 197.489\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 196.061\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00728\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lim domain only 7; zinc-finger domain-containing protein; lomp protein; f-box only protein 20; f-box protein fbx20. [source:refseq;acc:nm\_005358]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 216.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.801\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00727\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2108\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent argininosuccinate lyase (ec 4.3.2.1) (arginosuccinase) (asal). [source:swissprot;acc:p04424]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 216.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00726\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2109\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ran-binding protein 2 (ranbp2) (nuclear pore complex protein nup358) (nucleoporin nup358) (358 kda nucleoporin) (p270). [source:swissprot;acc:p49792]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.032\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00718\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2110\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent conserved oligomeric golgi complex component 6. [source:swissprot;acc:q9y2v7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 211.099\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 209.607\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00712\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2111\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ran-binding protein 2-like 1 isoform 2; sperm membrane protein bs-63; ran-binding protein 2-like 1. [source:refseq;acc:nm\_032260]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.047\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.511\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00706\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2112\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna-directed rna polymerases iii 12.5 kda polypeptide (ec 2.7.7.6) (rna polymerase iii c11 subunit) (hsc11p) (hrpc11) (my010 protein). [source:swissprot;acc:q9y2y1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 223.415\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 224.989\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.00705\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ran-binding protein 2-like 1 isoform 2; sperm membrane protein bs-63; ran-binding protein 2-like 1. [source:refseq;acc:nm\_032260]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.055\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.533\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.007\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2114\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent triacylglycerol lipase, gastric precursor (ec 3.1.1.3) (gastric lipase) (gl). [source:swissprot;acc:p07098]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 214.632\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 213.14\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2115\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ba304i5.1 (novel lipase) (fragment). [source:sptrembl;acc:q96lg2]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2116\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lysosomal acid lipase/cholesteryl ester hydrolase precursor (ec 3.1.1.13) (lal) (acid cholesteryl ester hydrolase) (sterol esterase) (lipase a) (cholesteryl esterase). [source:swissprot;acc:p38571]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2117\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent seryl-trna synthetase, mitochondrial precursor (ec 6.1.1.11) (serine--trna ligase) (serrsmt). [source:swissprot;acc:q9np81]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent seryl-trna synthetase (ec 6.1.1.11) (serine--trna ligase) (serrs). [source:swissprot;acc:p49591]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent potassium channel modulatory factor 1; potassium channel modulatory factor; differentially expressed in branching tubulogenesis 91; zinc finger, zz domain containing 1. [source:refseq;acc:nm\_020122]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 221.248\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 222.788\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.00696\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2120\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent solute carrier family 23, member 1 (sodium-dependent vitamin c transporter 1) (hsvct1) (na(+)/l-ascorbic acid transporter 1) (yolk sac permease-like molecule 3). [source:swissprot;acc:q9uhi7]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heterogeneous nuclear ribonucleoprotein a3 (hnrnp a3) (d10s102). [source:swissprot;acc:p51991]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent galectin-9 (hom-hd-21) (ecalectin). [source:swissprot;acc:o00182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 206.473\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 207.911\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adp-ribosylation factor 4. [source:swissprot;acc:p18085]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 221.248\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 222.788\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent fused toes homolog; likely ortholog of mouse fused toes. [source:refseq;acc:nm\_022476]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent shc transforming protein. [source:swissprot;acc:p29353]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 289, id1 regulated; likely ortholog of mouse zfp289. [source:refseq;acc:nm\_032389]\vspace{3pt}}&&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/